Viewing Study NCT00955292


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT00955292
Status: TERMINATED
Last Update Posted: 2009-08-10
First Post: 2009-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
Sponsor: Cylene Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module